Bisperoxovanadium, a phospho‐tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotypeLaura Castaldi, Marina Bouché, Carlo Serra et al.|The FASEB Journal|2007Cited by 19
A Bimodal Modulation of the cAMP Pathway Is Involved in the Control of Myogenic Differentiation in L6 CellsFabio Naro, Georges Némoz, Hiba Komati et al.|Journal of Biological Chemistry|2003Cited by 17